Cargando…
Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
Metastatic disease in a cancer patient still remains a therapeutic challenge. Metastatic process involves many steps, during which malignant cells succeed to activate cellular pathways promoting survival in hostile environment, engraftment and growth at the distant site from the primary tumor. Melan...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817811/ https://www.ncbi.nlm.nih.gov/pubmed/29455657 http://dx.doi.org/10.1186/s12943-018-0795-z |